Abiopharma

Crescent Biopharma to Present at September Investor Conferences

Kura Oncology to Participate in Three Upcoming Investor Conferences

Zevra Therapeutics Announces Multiple Datasets on MIPLYFFA® (arimoclomol) to be Presented at the International Congress of Inborn Errors of Metabolism (ICIEM)

QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference

Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York

New Form 6-K - EDAP TMS SA Filed: 2025-08-28 AccNo: 0001171843-25-005622 Size: 232 KB

REGENXBIO to Participate in Upcoming Investor Conferences

New Form 8-K - NovoCure Ltd Filed: 2025-08-28 AccNo: 0001645113-25-000032 Size: 140 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Veeva Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation

Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Primary Large B-Cell Lymphomas of Immune-Privileged Sites, including Primary Vitreoretinal Lymphoma

Compugen - Compugen to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences